US Initiative To End HIV Epidemic Will Boost PrEP Access
Executive Summary
'Number of different initiatives' coming in next several months to make drugs more affordable, including for PrEP prophylaxis, HHS Assistant Secretary for Health Giroir says. Multi-agency approach is key strategy.
You may also be interested in...
Drug Pricing Avoids The Limelight During State Of The Union Address
President Trump did not offer any new proposals on drug pricing during an evening featuring campaign theatrics on both sides.
Giroir Becomes Acting US FDA Commissioner, Giving Agency Experienced Political Hand
Assistant HHS secretary for health has led policy development for several offices since his 2018 confirmation and also has industry and clinical experience.
Keeping Track: NME Approvals For Evenity And Balversa; Non-NME Approvals For Dovato And Keytruda; But An RTF For Fintepla
The latest drug development news and highlights from our US FDA Performance Tracker.